These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 23821878)
1. Minimising pain response during routine infant immunisation. McGowan A; Cottrell S; Roberts R; Lankshear A Community Pract; 2013 Jun; 86(6):24-8. PubMed ID: 23821878 [TBL] [Abstract][Full Text] [Related]
2. Order of vaccine injection and infant pain response. Ipp M; Parkin PC; Lear N; Goldbach M; Taddio A Arch Pediatr Adolesc Med; 2009 May; 163(5):469-72. PubMed ID: 19414694 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995 [TBL] [Abstract][Full Text] [Related]
5. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety. Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA; Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ; J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD; Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186 [TBL] [Abstract][Full Text] [Related]
8. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life. Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348 [TBL] [Abstract][Full Text] [Related]
9. Vaccine-related pain: randomised controlled trial of two injection techniques. Ipp M; Taddio A; Sam J; Gladbach M; Parkin PC Arch Dis Child; 2007 Dec; 92(12):1105-8. PubMed ID: 17686797 [TBL] [Abstract][Full Text] [Related]
10. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
11. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related]
12. A reader responds to "Rapid injections trump slow for minimizing injection pain". Scott IG Medscape J Med; 2008 Apr; 10(4):92. PubMed ID: 18504491 [No Abstract] [Full Text] [Related]
13. The pain response of infants in Turkey to vaccination in different injection sites. Celebioglu A; Akpinar RB; Tezel A Appl Nurs Res; 2010 May; 23(2):101-5. PubMed ID: 20420997 [TBL] [Abstract][Full Text] [Related]
15. Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. Diggle L; Deeks JJ; Pollard AJ BMJ; 2006 Sep; 333(7568):571. PubMed ID: 16891328 [TBL] [Abstract][Full Text] [Related]
16. Prospective assessment of the effect of needle length and injection site on the risk of local reactions to the fifth diphtheria-tetanus-acellular pertussis vaccination. Jackson LA; Starkovich P; Dunstan M; Yu O; Nelson J; Dunn J; Rees T; Zavitkovsky A; Maus D; Froeschle JE; Decker M Pediatrics; 2008 Mar; 121(3):e646-52. PubMed ID: 18310184 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450 [TBL] [Abstract][Full Text] [Related]
19. Vaccination site and risk of local reactions in children 1 through 6 years of age. Jackson LA; Peterson D; Nelson JC; Marcy SM; Naleway AL; Nordin JD; Donahue JG; Hambidge SJ; Balsbaugh C; Baxter R; Marsh T; Madziwa L; Weintraub E Pediatrics; 2013 Feb; 131(2):283-9. PubMed ID: 23319538 [TBL] [Abstract][Full Text] [Related]
20. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]